• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性大结节性肾上腺增生(PMAH)所致库欣综合征的异质性病因概述。

An Overview of the Heterogeneous Causes of Cushing Syndrome Resulting From Primary Macronodular Adrenal Hyperplasia (PMAH).

作者信息

Charchar Helaine Laiz Silva, Fragoso Maria Candida Barisson Villares

机构信息

Unidade de Suprarrenal, Laboratório de Hormônios e Genética Molecular (LIM/42), Divisão de Endocrinologia e Metabologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brasil.

出版信息

J Endocr Soc. 2022 Mar 17;6(5):bvac041. doi: 10.1210/jendso/bvac041. eCollection 2022 May 1.

DOI:10.1210/jendso/bvac041
PMID:35402764
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8989153/
Abstract

Primary macronodular adrenal hyperplasia (PMAH) is considered a rare cause of adrenal Cushing syndrome, is pituitary ACTH-independent, generally results from bilateral adrenal macronodules (>1 cm), and is often associated with variable cortisol secretion, resulting in a heterogeneous clinical presentation. Recent advances in the molecular pathogenesis of PMAH have offered new insights into the comprehension of this heterogeneous and complex adrenal disorder. Different molecular mechanisms involving the actors of the cAMP/protein kinase A pathway have been implicated in the development of PMAH, including germline and/or somatic molecular defects such as hyperexpression of the G-protein aberrant receptors and pathogenic variants of , , , and . Nevertheless, since 2013, the gene is believed to be a major genetic cause of PMAH, accounting for more than 80% of the familial forms of PMAH and 30% of apparently sporadic cases, except in food-dependent Cushing syndrome in which is not involved. Recently, 2 independent groups have identified that the tumor suppressor gene is responsible for PMAH associated specifically with food-dependent Cushing syndrome. Consequently, PMAH has been more frequently genetically associated than previously assumed. This review summarizes the most important aspects, including hormone secretion, clinical presentation, radiological imaging, and molecular mechanisms, involved in familial Cushing syndrome associated with PMAH.

摘要

原发性大结节性肾上腺增生(PMAH)被认为是肾上腺库欣综合征的罕见病因,不依赖垂体促肾上腺皮质激素(ACTH),通常由双侧肾上腺大结节(>1cm)引起,且常伴有皮质醇分泌变化,导致临床表现异质性。PMAH分子发病机制的最新进展为理解这种异质性和复杂性肾上腺疾病提供了新的见解。涉及环磷酸腺苷/蛋白激酶A途径相关因子的不同分子机制与PMAH的发生有关,包括种系和/或体细胞分子缺陷,如G蛋白异常受体的过度表达以及、、和的致病变异。然而,自2013年以来,基因被认为是PMAH的主要遗传原因,除了与食物依赖型库欣综合征无关外,它占PMAH家族形式的80%以上以及明显散发病例的30%。最近,两个独立的研究小组发现肿瘤抑制基因与特定的食物依赖型库欣综合征相关的PMAH有关。因此,PMAH在遗传上的相关性比以前认为的更为常见。本综述总结了与PMAH相关的家族性库欣综合征所涉及的最重要方面,包括激素分泌、临床表现、放射影像学和分子机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f683/8989153/894dc84c070a/bvac041f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f683/8989153/40296732b53d/bvac041f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f683/8989153/6a0c56cc5a52/bvac041f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f683/8989153/894dc84c070a/bvac041f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f683/8989153/40296732b53d/bvac041f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f683/8989153/6a0c56cc5a52/bvac041f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f683/8989153/894dc84c070a/bvac041f0003.jpg

相似文献

1
An Overview of the Heterogeneous Causes of Cushing Syndrome Resulting From Primary Macronodular Adrenal Hyperplasia (PMAH).原发性大结节性肾上腺增生(PMAH)所致库欣综合征的异质性病因概述。
J Endocr Soc. 2022 Mar 17;6(5):bvac041. doi: 10.1210/jendso/bvac041. eCollection 2022 May 1.
2
Genetics of primary macronodular adrenal hyperplasia.原发性大结节性肾上腺增生的遗传学
Presse Med. 2018 Jul-Aug;47(7-8 Pt 2):e139-e149. doi: 10.1016/j.lpm.2018.07.002. Epub 2018 Jul 31.
3
Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma.ARMC5肿瘤综合征的分子和临床证据:生殖系和体细胞同时发生的失活突变与原发性大结节性肾上腺增生和脑膜瘤均相关。
J Clin Endocrinol Metab. 2015 Jan;100(1):E119-28. doi: 10.1210/jc.2014-2648.
4
ARMC5 mutations are a frequent cause of primary macronodular adrenal Hyperplasia.ARMC5基因突变是原发性大结节性肾上腺增生的常见病因。
J Clin Endocrinol Metab. 2014 Aug;99(8):E1501-9. doi: 10.1210/jc.2013-4237. Epub 2014 Apr 7.
5
Primary macronodular adrenal hyperplasia (PMAH) can be generated by a new ARMC5 germline variant (c.52C>T (p.Gln18X)).原发性巨结节性肾上腺增生症(PMAH)可由 ARMC5 种系新变异(c.52C>T(p.Gln18X))引起。
Endocr J. 2020 Dec 28;67(12):1179-1186. doi: 10.1507/endocrj.EJ20-0163. Epub 2020 Jul 23.
6
GERMLINE DELETION OF ARMC5 IN FAMILIAL PRIMARY MACRONODULAR ADRENAL HYPERPLASIA.家族性原发性大结节性肾上腺皮质增生中ARMC5的种系缺失
Endocr Pract. 2015 Oct;21(10):1152-60. doi: 10.4158/EP15756.OR. Epub 2015 Jul 27.
7
MicroRNA expression signature and target prediction in familial and sporadic primary macronodular adrenal hyperplasia (PMAH).家族性和散发性原发性大结节性肾上腺增生症(PMAH)中的 microRNA 表达特征和靶基因预测。
BMC Endocr Disord. 2022 Jan 5;22(1):11. doi: 10.1186/s12902-021-00910-7.
8
Alterations in Primary Macronodular Adrenal Hyperplasia (PMAH) and the Clinical State of Variant Carriers.原发性大结节性肾上腺增生(PMAH)的改变及变异携带者的临床状况
J Endocr Soc. 2019 Jul 23;3(10):1837-1846. doi: 10.1210/js.2019-00210. eCollection 2019 Oct 1.
9
Allelic Variants of in Patients With Adrenal Incidentalomas and in Patients With Cushing's Syndrome Associated With Bilateral Adrenal Nodules.肾上腺意外瘤患者和双侧肾上腺结节性库欣综合征患者中 的等位基因变异。
Front Endocrinol (Lausanne). 2020 Feb 7;11:36. doi: 10.3389/fendo.2020.00036. eCollection 2020.
10
The role of ARMC5 in human cell cultures from nodules of primary macronodular adrenocortical hyperplasia (PMAH).在原发性大结节性肾上腺皮质增生症(PMAH)结节的人类细胞培养物中 ARMC5 的作用。
Mol Cell Endocrinol. 2018 Jan 15;460:36-46. doi: 10.1016/j.mce.2017.06.027. Epub 2017 Jul 1.

引用本文的文献

1
The mutational landscape of ARMC5 in Primary Bilateral Macronodular Adrenal Hyperplasia: an update.原发性双侧大结节性肾上腺增生中ARMC5的突变图谱:最新进展
Orphanet J Rare Dis. 2025 Feb 5;20(1):51. doi: 10.1186/s13023-025-03554-1.
2
Primary unilateral macronodular adrenal hyperplasia with concomitant glucocorticoid and androgen excess and KDM1A inactivation.原发性单侧巨结节性肾上腺增生伴糖皮质激素和雄激素过多及 KDM1A 失活。
Eur J Endocrinol. 2024 Aug 30;191(3):334-344. doi: 10.1093/ejendo/lvae106.
3
Pituitary Macroadenoma With Macronodular Adrenal Hyperplasia and Novel Armadillo Repeat-Containing Protein 5 (ARMC5) Mutation.

本文引用的文献

1
KDM1A inactivation causes hereditary food-dependent Cushing syndrome.KDM1A 失活导致遗传性食物依赖型库欣综合征。
Genet Med. 2022 Feb;24(2):374-383. doi: 10.1016/j.gim.2021.09.018. Epub 2021 Nov 30.
2
Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study.GIP 依赖性双侧大结节性肾上腺增生伴库欣综合征中 KDM1A 的缺失:一项多中心、回顾性、队列研究。
Lancet Diabetes Endocrinol. 2021 Dec;9(12):813-824. doi: 10.1016/S2213-8587(21)00236-9. Epub 2021 Oct 13.
3
Cardiovascular complications of mild autonomous cortisol secretion.
垂体大腺瘤伴大结节性肾上腺增生及新型含犰狳重复序列蛋白5(ARMC5)突变
JCEM Case Rep. 2024 Jan 12;2(2):luad138. doi: 10.1210/jcemcr/luad138. eCollection 2024 Feb.
4
Adrenal Cushing's syndrome in children.儿童库欣综合征。
Front Endocrinol (Lausanne). 2023 Dec 12;14:1329082. doi: 10.3389/fendo.2023.1329082. eCollection 2023.
5
A Novel Germline Variant in Primary Macronodular Adrenal Hyperplasia Using Whole-Exome Sequencing.利用全外显子组测序发现原发性大结节性肾上腺增生中的一种新型种系变异。
Diagnostics (Basel). 2022 Dec 2;12(12):3028. doi: 10.3390/diagnostics12123028.
6
Cushing´s syndrome due to bilateral adrenal cortical disease: Bilateral macronodular adrenal cortical disease and bilateral micronodular adrenal cortical disease.库欣综合征由于双侧肾上腺皮质疾病:双侧大结节性肾上腺皮质疾病和双侧小结节性肾上腺皮质疾病。
Front Endocrinol (Lausanne). 2022 Aug 5;13:913253. doi: 10.3389/fendo.2022.913253. eCollection 2022.
轻度自主皮质醇分泌的心血管并发症。
Best Pract Res Clin Endocrinol Metab. 2021 Mar;35(2):101494. doi: 10.1016/j.beem.2021.101494. Epub 2021 Feb 23.
4
Annual review of LSD1/KDM1A inhibitors in 2020.2020 年 LSD1/KDM1A 抑制剂的年度回顾。
Eur J Med Chem. 2021 Mar 15;214:113254. doi: 10.1016/j.ejmech.2021.113254. Epub 2021 Feb 3.
5
ARMC5 Alterations in Patients With Sporadic Neuroendocrine Tumors and Multiple Endocrine Neoplasia Type 1 (MEN1).散发性神经内分泌肿瘤和多发性内分泌腺瘤病 1 型(MEN1)患者的 ARMC5 改变。
J Clin Endocrinol Metab. 2020 Dec 1;105(12):e4531-42. doi: 10.1210/clinem/dgaa631.
6
Hereditary Predisposition to Hematopoietic Neoplasms: When Bloodline Matters for Blood Cancers.遗传性造血系统肿瘤易感性:当血液癌症与家族史有关。
Mayo Clin Proc. 2020 Jul;95(7):1482-1498. doi: 10.1016/j.mayocp.2019.12.013. Epub 2020 Jun 19.
7
Adrenal Incidentaloma.肾上腺意外瘤。
Endocr Rev. 2020 Dec 1;41(6):775-820. doi: 10.1210/endrev/bnaa008.
8
Adrenocortical hyperplasia: A multifaceted disease.肾上腺皮质增生症:一种多方面的疾病。
Best Pract Res Clin Endocrinol Metab. 2020 May;34(3):101386. doi: 10.1016/j.beem.2020.101386. Epub 2020 Feb 4.
9
Update of Genetic and Molecular Causes of Adrenocortical Hyperplasias Causing Cushing Syndrome.导致库欣综合征的肾上腺皮质增生症的遗传和分子病因学的更新。
Horm Metab Res. 2020 Aug;52(8):598-606. doi: 10.1055/a-1061-7349. Epub 2020 Feb 25.
10
Diagnosis and management of primary bilateral macronodular adrenal hyperplasia.原发性双侧巨结节性肾上腺增生的诊断与治疗。
Endocr Relat Cancer. 2019 Oct 1;26(10):R567-R581. doi: 10.1530/ERC-19-0240.